PAVO
Phase 2 Terminated
22 enrolled 17 charts
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Phase 2 Terminated
180 enrolled 16 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Terminated
199 enrolled 8 charts
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
Adjuvant Aspirin Treatment for Colon Cancer Patients
Phase 3 Terminated
1,040 enrolled 11 charts
Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps
Phase NA Terminated
36 enrolled 9 charts
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
Phase 1/2 Terminated
3 enrolled 6 charts
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
46 enrolled 21 charts
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Phase 2 Terminated
12 enrolled 5 charts
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Phase 2 Terminated
3 enrolled 5 charts
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
Phase 1 Terminated
78 enrolled 39 charts
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase 1 Terminated
3 enrolled 5 charts
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Phase 1 Terminated
7 enrolled 8 charts
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Phase 3 Terminated
406 enrolled 14 charts
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
Phase 3 Terminated
859 enrolled 8 charts
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Phase 1/2 Terminated
82 enrolled 14 charts
ABLATE
Phase 2 Terminated
2 enrolled 5 charts
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Phase 1 Terminated
4 enrolled 6 charts
FANG-CLM
Phase 2 Terminated
3 enrolled 9 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)
Phase 1 Terminated
31 enrolled 28 charts
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Phase 2 Terminated
19 enrolled 32 charts
PARAGON
Phase 1/2 Terminated
4 enrolled 5 charts
ADAPT
Phase 2 Terminated
27 enrolled 10 charts
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase 3 Terminated
32 enrolled 14 charts
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Phase 2 Terminated
7 enrolled 1 chart
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
Phase 2 Terminated
39 enrolled 6 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Terminated
25 enrolled 10 charts
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Phase 2 Terminated
5 enrolled 5 charts
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
Phase 2 Terminated
65 enrolled 8 charts
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Phase 2 Terminated
10 enrolled 7 charts
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
Phase 2 Terminated
11 enrolled 8 charts
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
1 enrolled 2 charts
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Phase 1/2 Terminated
5 enrolled 7 charts
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Phase 2 Terminated
1 enrolled 5 charts
SIGNATURE
Phase 2 Terminated
10 enrolled 9 charts
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
Phase 2 Terminated
1 enrolled 4 charts
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Terminated
39 enrolled 9 charts
Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
Phase NA Terminated
2 enrolled 4 charts
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
Phase 2 Terminated
1 enrolled 7 charts
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
Phase 1/2 Terminated
19 enrolled 11 charts
Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
Phase 2 Terminated
13 enrolled 5 charts
Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
Phase 2 Terminated
30 enrolled 10 charts
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Phase 3 Terminated
72 enrolled 15 charts
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
Phase 2 Terminated
10 enrolled 6 charts